Low Volume RiseWell, this is my take on the last trading sessions.
Low volume, SP increase.
No one is selling or very few sellers and new buyers paying the price to get in.
Current shareholders are increasingly believing that SP should be higher.
New shareholders willing to take the risk vs. the reward.
If we hit high volume, it will be indicative that SP will have plateau at a level.
We are not there yet!
Technical indicator show that there is room for more increase!
Looks good.
I am going all the way with BNC. I'll wait for results.
The profile pre-pivotal results is the best I ever seen in years.
No safety issue and CR (complete responses)
CRs... you can't argue with that! It means no more cancer! no more cancer!
PR well you can argue about how much the tumor shrank or did did shrank at all...
SD (stable disease) well could be unrelated to the drug... who knows...
CR at 64% on 51 patients (a decent population I must say!).
Testing on another 100 patients at max dosage (ie 8mg)
2 buffers for success....
1) Higher dosage than in PII - the more the better, the more effective (4mg vs. 8mg) Should be 2X more effective
2) SPA = 20% of CR = success ... so we have as a margin of error.
3) Drop out not an issue - no safety concern thus far.
I predict something higher than 40% of efficacy.
IF so, BNC goes very high and ENDO will fork out the cash to buy this company.